The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -9.38%. However, over the last six months, the performance has been stronger by -6.70%. The price of ROIV decreased -4.88% over the last 30 days. And in the last five days, it has surged by 2.68%.
Roivant Sciences Ltd saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $13.06 on 09/09/24, while the lowest price for the same duration was marked at $9.76 on 03/19/24.
52-week price history of ROIV Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Roivant Sciences Ltd’s current trading price is -17.89% away from its 52-week high, while its distance from the 52-week low is 9.84%. The stock’s price range during this period has varied between$9.76 and $13.06. The Roivant Sciences Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 3.94 million for the day, a figure considerably lower than their average daily volume of 4.62 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Roivant Sciences Ltd (ROIV) has experienced a quarterly decline of -4.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.65B and boasts a workforce of 908 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.54, with a change in price of -1.05. Similarly, Roivant Sciences Ltd recorded 4,553,767 in trading volume during the last 100 days, posting a change of -8.92%.
ROIV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ROIV Stock Stochastic Average
Roivant Sciences Ltd’s raw stochastic average for the past 50 days is presently 18.81%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 33.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.80% and 26.77%, respectively.
